Cargando…

Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities

INTRODUCTION/OBJECTIVE: The Canadian Network for Observational Drug Effect Studies (CNODES), a network of researchers and databases, is a collaborating center of the Drug Safety and Effectiveness Network. CNODES’ main mandate is to conduct observational studies of drug safety based on queries develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Platt, Robert W., Dormuth, Colin R., Chateau, Dan, Filion, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AcademyHealth 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909373/
https://www.ncbi.nlm.nih.gov/pubmed/27376096
http://dx.doi.org/10.13063/2327-9214.1221
_version_ 1782437829561810944
author Platt, Robert W.
Dormuth, Colin R.
Chateau, Dan
Filion, Kristian
author_facet Platt, Robert W.
Dormuth, Colin R.
Chateau, Dan
Filion, Kristian
author_sort Platt, Robert W.
collection PubMed
description INTRODUCTION/OBJECTIVE: The Canadian Network for Observational Drug Effect Studies (CNODES), a network of researchers and databases, is a collaborating center of the Drug Safety and Effectiveness Network. CNODES’ main mandate is to conduct observational studies of drug safety based on queries developed and submitted by Health Canada and other federal, provincial, and territorial stakeholders. Through a case study we explore several methodological opportunities and challenges that arise in distributed pharmacoepidemiology networks. CASE STUDY: We use as a case study a study of proton pump inhibitors and hospitalization for community-acquired pneumonia. Challenges arise in the design and conduct of studies at individual sites, and then with processes and methods for combining data. On the other hand, distributed networks provide opportunities, such as the ability to detect and understand heterogeneity, in sample sizes that would typically be impossible for a single study. CONCLUSIONS: Networks such as CNODES provide the opportunity to detect and quantify important safety signals from administrative data, and provide many challenges for methods research in pharmacoepidemiology using distributed data. As networks increase in size and scope of research questions, the need for methodological developments should continue to grow.
format Online
Article
Text
id pubmed-4909373
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AcademyHealth
record_format MEDLINE/PubMed
spelling pubmed-49093732016-07-01 Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities Platt, Robert W. Dormuth, Colin R. Chateau, Dan Filion, Kristian EGEMS (Wash DC) Articles INTRODUCTION/OBJECTIVE: The Canadian Network for Observational Drug Effect Studies (CNODES), a network of researchers and databases, is a collaborating center of the Drug Safety and Effectiveness Network. CNODES’ main mandate is to conduct observational studies of drug safety based on queries developed and submitted by Health Canada and other federal, provincial, and territorial stakeholders. Through a case study we explore several methodological opportunities and challenges that arise in distributed pharmacoepidemiology networks. CASE STUDY: We use as a case study a study of proton pump inhibitors and hospitalization for community-acquired pneumonia. Challenges arise in the design and conduct of studies at individual sites, and then with processes and methods for combining data. On the other hand, distributed networks provide opportunities, such as the ability to detect and understand heterogeneity, in sample sizes that would typically be impossible for a single study. CONCLUSIONS: Networks such as CNODES provide the opportunity to detect and quantify important safety signals from administrative data, and provide many challenges for methods research in pharmacoepidemiology using distributed data. As networks increase in size and scope of research questions, the need for methodological developments should continue to grow. AcademyHealth 2016-05-18 /pmc/articles/PMC4909373/ /pubmed/27376096 http://dx.doi.org/10.13063/2327-9214.1221 Text en All eGEMs publications are licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Articles
Platt, Robert W.
Dormuth, Colin R.
Chateau, Dan
Filion, Kristian
Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title_full Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title_fullStr Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title_full_unstemmed Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title_short Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
title_sort observational studies of drug safety in multi-database studies: methodological challenges and opportunities
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909373/
https://www.ncbi.nlm.nih.gov/pubmed/27376096
http://dx.doi.org/10.13063/2327-9214.1221
work_keys_str_mv AT plattrobertw observationalstudiesofdrugsafetyinmultidatabasestudiesmethodologicalchallengesandopportunities
AT dormuthcolinr observationalstudiesofdrugsafetyinmultidatabasestudiesmethodologicalchallengesandopportunities
AT chateaudan observationalstudiesofdrugsafetyinmultidatabasestudiesmethodologicalchallengesandopportunities
AT filionkristian observationalstudiesofdrugsafetyinmultidatabasestudiesmethodologicalchallengesandopportunities